BioNTech SE

XNAS

Last traded price · USD

$90.94

+0.26%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:58 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $90.70
Volume: 1,616
Day's high: —
Day's low: —

In brief

BioNTech SE is a US-listed company listed on Nasdaq, valued at about $22.84B.
Its shares closed at $90.70 on 4 Nov 2026, down 13.5% over the past year.
From India you can buy BNTX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy BioNTech SE (BNTX) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole BNTX share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade BNTX options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Below its 50- and 200-day averages
The 4 Nov 2026 close of $90.70 was 5.2% below its 50-day average ($95.67) and 6.3% below its 200-day average ($96.82). It has closed below the 200-day for 25 sessions, since 1 Oct 2026. The 50-day average crossed below the 200-day on 2 Nov 2026, 2 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY over 1 year
1 month: −5.3% (SPY −1.6%). 3 months: −1.6% (SPY −0.4%). 1 year: −13.5% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BNTX, SPY · as of 4 Nov 2026
25% of the way up its 52-week range
Closed at $90.70 on 4 Nov 2026: 26.9% below the 52-week high of $124.00 (22 Jan 2026) and 14.1% above the low of $79.52 (10 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 0.9% of shares outstanding
2.3M shares were sold short at the 15 Oct 2026 settlement, 0.9% of the 252.9M shares outstanding; covering them would take 2.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−5.3%

6 months−4.8%

1 year−13.5%

5 years−66.9%

Newswire

About

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Website

Notable moves

August 19, 2026
+21.96%
December 6, 2021
−18.67%
November 5, 2021
−20.92%

BioNTech SE

XNAS

Last traded price · USD

$90.94

+0.26%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:58 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $90.70
Volume: 1,616
Day's high: —
Day's low: —

In brief

BioNTech SE is a US-listed company listed on Nasdaq, valued at about $22.84B.
Its shares closed at $90.70 on 4 Nov 2026, down 13.5% over the past year.
From India you can buy BNTX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy BioNTech SE (BNTX) shares from India?

Do I need the price of a whole BNTX share to invest?

How much can I invest in US stocks in a year?

Can I trade BNTX options or futures?

Insights

Quotes run fifteen minutes behind.

Below its 50- and 200-day averages
The 4 Nov 2026 close of $90.70 was 5.2% below its 50-day average ($95.67) and 6.3% below its 200-day average ($96.82). It has closed below the 200-day for 25 sessions, since 1 Oct 2026. The 50-day average crossed below the 200-day on 2 Nov 2026, 2 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY over 1 year
1 month: −5.3% (SPY −1.6%). 3 months: −1.6% (SPY −0.4%). 1 year: −13.5% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BNTX, SPY · as of 4 Nov 2026
25% of the way up its 52-week range
Closed at $90.70 on 4 Nov 2026: 26.9% below the 52-week high of $124.00 (22 Jan 2026) and 14.1% above the low of $79.52 (10 Mar 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 0.9% of shares outstanding
2.3M shares were sold short at the 15 Oct 2026 settlement, 0.9% of the 252.9M shares outstanding; covering them would take 2.1 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−5.3%

6 months−4.8%

1 year−13.5%

5 years−66.9%

Newswire

About

Website

Notable moves

August 19, 2026
+21.96%
December 6, 2021
−18.67%
November 5, 2021
−20.92%

BioNTech SE

BioNTech SE in brief

Below its 50- and 200-day averages

Behind SPY over 1 year

25% of the way up its 52-week range

Short interest at 0.9% of shares outstanding

BioNTech SE

BioNTech SE in brief

Below its 50- and 200-day averages

Behind SPY over 1 year

25% of the way up its 52-week range

Short interest at 0.9% of shares outstanding